Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(18 sites)
Australia
Concord Repatriation General Hospital, Concord, New South Wales Shoalhaven Cancer Care Centre, Nowra, New South Wales Wollongong Hospital, Wollongong, New South Wales Royal Adelaide Hospital, Adelaide, South Australia Austin Hospital, Heidelberg, Victoria Sir Charles Gairdner Hospital, Perth, Western Australia Canada
Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta BCCA - Vancouver, Vancouver, British Columbia Dr. H. Bliss Murphy Cancer Centre, St. John's, Newfoundland and Labrador QEII Health Sciences Centre, Halifax, Nova Scotia Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario London Health Sciences Centre Research Inc., London, Ontario Ottawa Hospital Research Institute, Ottawa, Ontario University Health Network, Toronto, Ontario The Jewish General Hospital, Montreal, Quebec The Research Institute of the McGill University, Montreal, Quebec CIUSSS de l'Estrie - Centre hospitalier, Sherbrooke, Quebec Allan Blair Cancer Centre, Regina, Saskatchewan Last updated February 2026